In the human immune response a key role is played by biophysics: cell mechanics, nanostructure, and dynamics. An emerging field of immunoengineering is exploiting this insight with new biomaterials and devices, with great success in controlling cellular activation in T and Natural Killer cells. But will these biophysical approaches compete with or complement biochemical and genetic methods in clinical application?
